Atlas Trials

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Clinical trial NCT01077700 · COMPLETED

Trial details

NCT number
NCT01077700
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive Deficits in Schizophrenia
Start date
2010-03-01
Primary completion
2011-07-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.